U.S. lawmakers on Wednesday accused three major pharmaceutical companies of “coordinated obstruction” and “apparent efforts to stonewall” an investigation on generic drug prices launched in 2014.
Chairman of the House Committee on Oversight, Elijah Cummings, D-Md., along with Sen. Bernie Sanders, I-Vt., sent letters to Mylan, Teva Pharmaceutical and Heritage Pharmaceuticals asking them to turn over documents, according to a joint statement Wednesday.
Democrats, who regained control of the House this year, listed lowering prescription drug costs as one of their top priorities. Cummings, along with Sanders and Rep. Ro Khanna, D-Ca., introduced three bills earlier this year aimed at lowering drug costs.
Spending on prescription drugs in the U.S. increased 0.4% in 2017 to $333.4 billion, according to the latest data from the Centers for Medicare and Medicaid Services.
This story is developing. Please check back for updates.